scPharmaceuticals to Present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference

Rhea-AI Summary

BURLINGTON, Mass., Nov. 19, 2020 – scPharmaceuticals (Nasdaq: SCPH) announced that John Tucker, the president and CEO, will present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference on December 3 at 11:20 AM EST. This presentation highlights the company's focus on optimizing infused therapies and reducing healthcare costs. A live webcast of the presentation will be available on the company's Investor Relations website.

scPharmaceuticals is dedicated to developing innovative products aimed at improving health outcomes, particularly in outpatient care for heart failure and infectious diseases.

BURLINGTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 3 at 11:20am EST.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

Media:
Kate Coyle
ICR Inc., 203-682-8210
kate.coyle@icrinc.com

FAQ

When is the scPharmaceuticals presentation at the Evercore ISI Virtual HealthCONx Conference?

John Tucker will present on December 3, 2020, at 11:20 AM EST.

How can I watch the scPharmaceuticals presentation?

A live webcast can be accessed under 'News & Events' on the scPharmaceuticals Investor Relations website.

What is the focus of scPharmaceuticals?

scPharmaceuticals focuses on developing products to optimize the delivery of infused therapies and reduce healthcare costs.

Where is scPharmaceuticals located?

scPharmaceuticals is headquartered in Burlington, Massachusetts.

What are scPharmaceuticals' lead programs targeting?

The lead programs focus on subcutaneous, self-administration of IV-strength treatments for heart failure and infectious diseases.